Mutational signatures of DNA damage and repair processes. (360G-Wellcome-101126_B_13_Z)

£3,295,091

DNA in all cells is prone to mutagenesis, with somatic mutations making key contributions to human diseases such as cancer and neurodegenerative diseases, and to aging itself. Mutations are the consequence of exogenous or endogenous mutagenic influences (including radiations and DNA-damaging chemicals) and also result from enzymatic DNA modifications or low fidelity DNA synthesis by specialized DNA polymerases. Mutations are generally prevented by the cellular DNA-repair machinery and defective functioning of this machinery can markedly increase mutation rates. Different mutational processes leave different, characteristic signatures of somatic mutations on the exposed cellular genome. Notably, recent analyses of cancer genomes have revealed several novel mutational signatures, the biological bases of which are predominantly unknown. To define somatic mutational processes operative in cells, and in particular their influences on human disease, we propose to systematically survey, at th e genome-wide level, mutational signatures generated by exposures to known or putative human carcinogens, defective DNA repair/editing processes or dysfunction of other cellular processes. These studies will provide a set of mutational signatures with known underlying causes for subsequent matching to signatures found in normal or diseased human cells and will expand our knowledge of how various cellular components influence mutagenesis.

Where is this data from?

This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.

Grant Details

Amount Awarded 3295091
Applicant Surname Stratton
Approval Committee Strategic Awards Committee
Award Date 2013-04-17T00:00:00+00:00
Financial Year 2012/13
Grant Programme: Title Strategic Award - Science
Internal ID 101126/B/13/Z
Lead Applicant Prof Sir Michael Stratton
Other Applicant(s) Dr Julian Sale, Dr Peter Campbell, Dr Serena Nik-Zainal, Dr Simon Boulton, Dr Ultan McDermott, Prof Anton Gartner, Prof David Phillips, Prof Ketan Patel, Prof Michael Neuberger, Prof Stephen Jackson
Partnership Value 3295091
Planned Dates: End Date 2019-04-30T00:00:00+00:00
Planned Dates: Start Date 2013-09-01T00:00:00+00:00
Recipient Org: Country United Kingdom
Region East of England